These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 103190

  • 21. Long-term (four year) clinical trial with tenoxicam and basis therapy in patients suffering from rheumatoid arthritis.
    Lalos J, Tsachalos P, Gallis L.
    Scand J Rheumatol Suppl; 1989; 80():67-70. PubMed ID: 2512637
    [Abstract] [Full Text] [Related]

  • 22. Is gold necessary in so called chrysotherapy?
    Munthe E, Jellum E.
    Scand J Rheumatol Suppl; 1983; 51():46-51. PubMed ID: 6426053
    [Abstract] [Full Text] [Related]

  • 23. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine.
    Domljan Z, Borso G, Marinković M, Winter Fudurić I, Pucar I, Cikes N.
    Acta Med Iugosl; 1987; 41(5):363-72. PubMed ID: 3128058
    [No Abstract] [Full Text] [Related]

  • 24. [A long-term clinical analysis of the rheumatoid patients treated by a combination of GST and CCA].
    Minami M, Kaneda K.
    Ryumachi; 1995 Oct; 35(5):780-91. PubMed ID: 8594657
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Should one use second-line agents such as gold and D-penicillamine in a patient with active rheumatoid arthritis and asymptomatic microscopic haematuria for which no cause can be determined?
    Bird HA.
    Br J Rheumatol; 1989 Feb; 28(1):39. PubMed ID: 2492869
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes.
    Hurst NP, Bell AL, Nuki G.
    Ann Rheum Dis; 1986 Jan; 45(1):37-43. PubMed ID: 3006610
    [Abstract] [Full Text] [Related]

  • 29. Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.
    Huskisson EC, Gibson TJ, Balme HW, Berry H, Burry HC, Grahame R, Hart FD, Henderson DR, Wojtulewski JA.
    Ann Rheum Dis; 1974 Nov; 33(6):532-5. PubMed ID: 4216306
    [No Abstract] [Full Text] [Related]

  • 30. Adverse reactions to D-penicillamine after gold toxicity.
    Dodd MJ, Griffiths ID, Thompson M.
    Br Med J; 1980 Jun 21; 280(6230):1498-500. PubMed ID: 6770953
    [Abstract] [Full Text] [Related]

  • 31. HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Dahlqvist SR, Ström H, Bjelle A, Möller E.
    Clin Rheumatol; 1985 Mar 21; 4(1):55-61. PubMed ID: 3157529
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effects of long-term aurothiomalate and D-penicillamine treatments on renal function and urinary excretion of prostanoids in patients with rheumatoid arthritis.
    Seppälä E, Lehtinen K, Isomäki H, Nissilä M, Harmoinen A, Mörsky P, Koivula T, Vapaatalo H.
    Int J Clin Pharmacol Res; 1988 Mar 21; 8(3):149-56. PubMed ID: 3136089
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Do penicillamine and Myocrisin act the same way in rheumatoid arthritis?
    Munthe E, Jellum E, Aaseth J.
    Rheumatol Rehabil; 1978 Mar 21; Suppl():105-8. PubMed ID: 103179
    [Abstract] [Full Text] [Related]

  • 36. A comparative trial of timegadine and D-penicillamine in rheumatoid arthritis.
    Mbuyi-Muamba JM, Dequeker J.
    Clin Rheumatol; 1983 Dec 21; 2(4):369-74. PubMed ID: 6678197
    [Abstract] [Full Text] [Related]

  • 37. Remission-inducing drugs in rheumatoid arthritis.
    Anastassiades TP.
    Can Med Assoc J; 1980 Feb 23; 122(4):405-15. PubMed ID: 6768438
    [Abstract] [Full Text] [Related]

  • 38. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.
    Munthe E, Kåss E.
    J Rheumatol Suppl; 1981 Feb 23; 7():107-11. PubMed ID: 6785435
    [Abstract] [Full Text] [Related]

  • 39. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
    Harth M, Keown PA, Orange J.
    J Rheumatol Suppl; 1983 Dec 23; 11():76-80. PubMed ID: 6230447
    [Abstract] [Full Text] [Related]

  • 40. How reliable is ESR as a measure of disease activity in rheumatoid arthritis treated with hydroxychloroquine?
    Dixon JS, Greenwood M, Bird HA.
    Clin Rheumatol; 1988 Jun 23; 7(2):262-6. PubMed ID: 2901304
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.